Leukotriene-B4 derivatives, in particular 7-methylcyclohexyl-LTB4 antagonists
    2.
    发明授权
    Leukotriene-B4 derivatives, in particular 7-methylcyclohexyl-LTB4 antagonists 失效
    白三烯-B4衍生物,特别是7-甲基环己基-TBB4拮抗剂

    公开(公告)号:US06340706B1

    公开(公告)日:2002-01-22

    申请号:US09424449

    申请日:2000-03-10

    IPC分类号: A61K3120

    CPC分类号: C07C405/0066 C07C405/00

    摘要: The invention relates to leukotriene B4 derivatives of general formula (I) in which R1 stands for CH2OH, CH3, CF3, COOR4, CONR5R6; R2 stands for H or an organic acid radical with 1-15 C atoms; R3 stands for H; R4 is hydrogen, C1-C10-alkyl, C3-C10-cycloalkyl, a C6-C10-aryl radical optionally substituted by 1-3 halogen, phenyl, C1-C4-alkyl, C1-C4-alkoxy, fluoromethyl, chloromethyl, trifluoromethyl, carboxyl or hydroxy, or CH2—CO—(C6-C10) aryl, or a 5-6 link ring with at least 1 heteroatom; A is a trans-, trans-CH═CH—CH═CH, a —CH2CH2—CH═CH— or a tetramethylene group; B is a C1-C10 linear or branched-chain aklylene group or the group (a) or (b); D is a direct bonding, oxygen, sulphur, —C≡C—, —CH═CR7, or a direct bonding with B. The invention also relates to salts thereof, having physiologically compatible bases and their cyclodextrin clathrates. The inventive substances can be used as pharmaceutical preparations

    摘要翻译: 本发明涉及通式(I)的白三烯B4衍生物,其中R1代表CH2OH,CH3,CF3,COOR4,CONR5R6; R2代表H或具有1-15个C原子的有机酸基团; R3代表H; R4是氢,C1-C10-烷基,C3-C10-环烷基,任选被1-3个卤素取代的C 6 -C 10 - 芳基,苯基,C 1 -C 4 - 烷基,C 1 -C 4 - 烷氧基,氟甲基,氯甲基,三氟甲基 ,羧基或羟基,或CH 2 -CO-(C 6 -C 10)芳基或具有至少1个杂原子的5-6连接环; A是反式 - 反式-CH = CH-CH = CH,-CH 2 CH 2 -CH = CH-或四亚甲基; B是C1-C10直链或支链亚氨基或基团(a)或(b); D是直接键合,氧,硫,-C = C - , - CH = CR7,或与B的直接键合。本发明还涉及其具有生理上相容的碱和它们的环糊精包合物的盐。 本发明的物质可以用作药物制剂

    Leukotriene B.sub.4 derivatives, in particular oximo-LTB.sub.4 -
antagonists
    4.
    发明授权
    Leukotriene B.sub.4 derivatives, in particular oximo-LTB.sub.4 - antagonists 失效
    白三烯B4衍生物,特别是oximo-LTB4拮抗剂

    公开(公告)号:US6160012A

    公开(公告)日:2000-12-12

    申请号:US423336

    申请日:2000-03-27

    摘要: Leukotriene-B.sub.4 derivatives of general formula (I), in which R.sub.1 represents H, CF.sub.3, CH.sub.2 OH, and R.sub.2 represents H or an organic acid radical; R.sup.3 symbolizes H, C.sub.1 -C.sub.14 alkyl, C.sub.3 -C.sub.10 cycloalkyl, or a 5- to 6-membered aromatic heterocyclic ring with at least 1 heteroatom; R.sub.4 means hydrogen, C.sub.1 -C.sub.10 alkyl, C.sub.3 -C.sub.10 cycloalkyl; A symbolizes a trans, trans--CH.dbd.CH--CH.dbd.CH, a --CH.sub.2 CH.sub.2 --CH.dbd.CH-- or a tetramethylene group; B symbolizes a C.sub.1 -C.sub.10 -- straight-chain or branched-chain alkylene group or group (a) or (b); D can mean a direct bond, oxygen, sulfur, --C.tbd.C--, --CH.dbd.CR.sub.7, or together with B can also mean a direct bond; R.sub.5 and R.sub.6 are the same or different and represent H or C.sub.1 -C.sub.4 alkyl, or R.sub.6 represents H and R.sub.5 represents C.sub.1 -C.sub.15 alkanoyl or R.sub.8 represents SO.sub.2 ; R.sub.7 means H, C.sub.1 -C.sub.5 alkyl, chlorine, bromine; R.sub.8 has the same meaning as R.sub.3, m means 1-3, o means 0-5, p means 0-5, X is a direct bond, oxygen, sulfur, an aromatic compound or heteroaromatic compound, Y is a C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.10 cycloalkyl, n is 2-5, and, if R.sub.4 means hydrogen, their salts with physiologically compatible bases and their cyclodextrin clathrates. The leukotriene derivatives are used as dermatological products. ##STR1##

    摘要翻译: PCT No.PCT / EP98 / 03139 Sec。 371日期2000年3月27日 102(e)日期2000年3月27日PCT提交1998年5月22日PCT公布。 第WO98 / 52915 PCT公开 日期:1月26日,通式(I)的白俄罗烯-B4衍生物,其中R1表示H,CF3,CH2OH和R2表示H或有机酸基; R3表示H,C1-C14烷基,C3-C10环烷基或具有至少1个杂原子的5至6元芳族杂环; R4表示氢,C1-C10烷基,C3-C10环烷基; A表示反式,反式-CH = CH-CH = CH,-CH 2 CH 2 -CH = CH-或四亚甲基; B表示C1-C10-直链或支链亚烷基或基团(a)或(b); D可以表示直接键,氧,硫,-C 3位C,-CH = CR 7,或与B一起也可以是直接键; R5和R6相同或不同,代表H或C1-C4烷基,或R6代表H,R5代表C1-C15烷酰基或R8代表SO2; R7表示H,C1-C5烷基,氯,溴; R8与R3相同,m表示1-3,o表示0-5,p表示0-5,X表示直接键,氧,硫,芳香族化合物或杂芳族化合物,Y表示C1〜C8烷基 ,C 3 -C 10环烷基,n为2-5,如果R 4表示氢,则其与生理上相容的碱和它们的环糊精包合物的盐。 白三烯衍生物用作皮肤病学产品。